लोड हो रहा है...

A Pooled Analysis of Gemcitabine Plus Docetaxel Versus Capecitabine Plus Docetaxel in Metastatic Breast Cancer

INTRODUCTION. In two randomized phase III trials of patients with metastatic breast cancer (MBC), gemcitabine-docetaxel (GD) and capecitabine-docetaxel (CD) had similar efficacy, but distinct safety profiles. METHODS. Data from two GD versus CD studies were pooled; overall survival (OS), progression...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Seidman, Andrew D., Chan, Stephen, Wang, Jin, Zhu, Chao, Xu, Cong, Xu, Binghe
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: AlphaMed Press 2014
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012969/
https://ncbi.nlm.nih.gov/pubmed/24705980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0428
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!